Found: 149
Select item for more details and to access through your institution.
Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting.
- Published in:
- Current Oncology, 2024, v. 31, n. 7, p. 3771, doi. 10.3390/curroncol31070278
- By:
- Publication type:
- Article
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
- By:
- Publication type:
- Article
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
- Published in:
- Clinical & Experimental Metastasis, 2024, v. 41, n. 2, p. 117, doi. 10.1007/s10585-024-10266-6
- By:
- Publication type:
- Article
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6853
- By:
- Publication type:
- Article
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 1, p. 37, doi. 10.1007/s40291-023-00679-6
- By:
- Publication type:
- Article
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5039, doi. 10.1007/s10238-023-01159-1
- By:
- Publication type:
- Article
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5413, doi. 10.1007/s10238-023-01235-6
- By:
- Publication type:
- Article
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
- By:
- Publication type:
- Article
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
- By:
- Publication type:
- Article
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1365, doi. 10.1007/s00262-022-03349-4
- By:
- Publication type:
- Article
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1381, doi. 10.1007/s00262-023-03366-x
- By:
- Publication type:
- Article
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 408, doi. 10.3390/cancers15020408
- By:
- Publication type:
- Article
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
- By:
- Publication type:
- Article
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
- Published in:
- Therapeutic Advances in Urology, 2023, v. 15, p. 1, doi. 10.1177/17562872231187216
- By:
- Publication type:
- Article
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6071, doi. 10.3390/cancers14246071
- By:
- Publication type:
- Article
Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6356, doi. 10.3390/jcm11216356
- By:
- Publication type:
- Article
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102444
- By:
- Publication type:
- Article
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4142, doi. 10.3390/cancers14174142
- By:
- Publication type:
- Article
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918413
- By:
- Publication type:
- Article
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.912699
- By:
- Publication type:
- Article
Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7741, doi. 10.3390/ijms23147741
- By:
- Publication type:
- Article
Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2644, doi. 10.3390/cancers14112644
- By:
- Publication type:
- Article
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092293
- By:
- Publication type:
- Article
Chronic Cancer Pain: Opioids within Tumor Microenvironment Affect Neuroinflammation, Tumor and Pain Evolution.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092253
- By:
- Publication type:
- Article
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 842, doi. 10.3390/jpm12050842
- By:
- Publication type:
- Article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 907, doi. 10.3390/cancers14040907
- By:
- Publication type:
- Article
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041038
- By:
- Publication type:
- Article
Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 688, doi. 10.3390/ijms23020688
- By:
- Publication type:
- Article
The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 1, p. 107, doi. 10.3390/biom12010107
- By:
- Publication type:
- Article
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 61, doi. 10.1007/s11523-021-00861-y
- By:
- Publication type:
- Article
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13519, doi. 10.3390/ijms222413519
- By:
- Publication type:
- Article
Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5989, doi. 10.3390/cancers13235989
- By:
- Publication type:
- Article
Cancer Immunotherapy: Current and Future Perspectives on a Therapeutic Revolution.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5246, doi. 10.3390/jcm10225246
- By:
- Publication type:
- Article
Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5229, doi. 10.3390/cancers13205229
- By:
- Publication type:
- Article
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 740, doi. 10.1002/onco.13842
- By:
- Publication type:
- Article
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z
- By:
- Publication type:
- Article
ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 2052, doi. 10.3390/cells10082052
- By:
- Publication type:
- Article
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3471, doi. 10.3390/cancers13143471
- By:
- Publication type:
- Article
Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not Enough.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3492, doi. 10.3390/cancers13143492
- By:
- Publication type:
- Article
Mechanosensation and Mechanotransduction in Natural Killer Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.688918
- By:
- Publication type:
- Article
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6237, doi. 10.3390/ijms22126237
- By:
- Publication type:
- Article
Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5522, doi. 10.3390/ijms22115522
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.634818
- By:
- Publication type:
- Article
Knock-Down of Mucolipin 1 Channel Promotes Tumor Progression and Invasion in Human Glioblastoma Cell Lines.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.578928
- By:
- Publication type:
- Article
La Roma Nord, dalla tranvia elettrica alla ferrovia regionale.
- Published in:
- Ingegneria Ferroviaria, 2021, v. 76, n. 4, p. 289
- By:
- Publication type:
- Article
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 880, doi. 10.1111/1759-7714.13852
- By:
- Publication type:
- Article
Treating Prostate Cancer by Antibody–Drug Conjugates.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1551, doi. 10.3390/ijms22041551
- By:
- Publication type:
- Article